Debbie L. Hay mainly focuses on Receptor, Receptor activity-modifying protein, Calcitonin gene-related peptide, Calcitonin receptor and Internal medicine. Her biological study spans a wide range of topics, including Signal transduction, Neuroscience, Pharmacology and Bioinformatics. The various areas that Debbie L. Hay examines in her Receptor activity-modifying protein study include Agonist, G protein-coupled receptor, RAMP2 and Receptor Activity-Modifying Protein 1.
Her research integrates issues of Calcitonin and Cell biology in her study of Calcitonin gene-related peptide. Her Calcitonin receptor study frequently intersects with other fields, such as CALCRL. Internal medicine is closely attributed to Endocrinology in her study.
Her main research concerns Receptor, Calcitonin gene-related peptide, Calcitonin receptor, Receptor activity-modifying protein and RAMP1. Debbie L. Hay has researched Receptor in several fields, including Calcitonin, Endocrinology and Pharmacology. As a part of the same scientific family, Debbie L. Hay mostly works in the field of Calcitonin gene-related peptide, focusing on Amylin and, on occasion, Peptide hormone.
Her Calcitonin receptor study which covers Enzyme-linked receptor that intersects with Interleukin-21 receptor. Her Receptor activity-modifying protein research is multidisciplinary, relying on both Plasma protein binding, Stereochemistry and CALCRL. Her RAMP1 research incorporates elements of Protein structure, RAMP2 and Receptor Activity-Modifying Protein 1.
Receptor, Calcitonin gene-related peptide, Calcitonin, G protein-coupled receptor and Cell biology are her primary areas of study. Debbie L. Hay studied Receptor and Amylin that intersect with Ligand. Her Calcitonin gene-related peptide study combines topics from a wide range of disciplines, such as Photophobia, Endocrinology and Pharmacology.
Debbie L. Hay regularly links together related areas like Receptor activity-modifying protein in her G protein-coupled receptor studies. Her work in Receptor activity-modifying protein addresses issues such as Receptor Activity-Modifying Protein 1, which are connected to fields such as Internalization. Her research in RAMP1 tackles topics such as RAMP2 which are related to areas like RAMP3, CALCRL and Corticotropin-releasing hormone receptor 1.
Debbie L. Hay mainly investigates Receptor, G protein-coupled receptor, Cell biology, Receptor activity-modifying protein and Adrenomedullin. She studies Receptor, namely Calcitonin gene-related peptide. The subject of her Calcitonin gene-related peptide research is within the realm of Internal medicine.
In her work, Calcitonin and Cell signaling is strongly intertwined with Calcitonin receptor, which is a subfield of Cell biology. Her Receptor activity-modifying protein research is multidisciplinary, incorporating perspectives in RAMP1, Amino acid peptide and Receptor Activity-Modifying Protein 1. Her RAMP1 study combines topics in areas such as Internalization, RAMP3, RAMP2 and CALCRL.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Oxyntomodulin inhibits food intake in the rat.
C. L. Dakin;I. Gunn;C. J. Small;C. M. B. Edwards.
GPCR modulation by RAMPs
Debbie L. Hay;David R. Poyner;Patrick M. Sexton.
Pharmacology & Therapeutics (2006)
Amylin: Pharmacology, Physiology, and Clinical Potential
Debbie L. Hay;Steve Chen;Thomas A. Lutz;David G. Parkes.
Pharmacological Reviews (2015)
Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25
Debbie L Hay;Michael L Garelja;David R Poyner;Christopher S Walker.
British Journal of Pharmacology (2018)
Pharmacological discrimination of calcitonin receptor - receptor activity modifying protein complexes
Debbie L Hay;George Christopoulos;Arthur Christopoulos;David R Poyner.
Molecular Pharmacology (2005)
Cryo-EM structure of the active, G s -protein complexed, human CGRP receptor
Yi Lynn Liang;Maryam Khoshouei;Maryam Khoshouei;Giuseppe Deganutti;Alisa Glukhova.
CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS.
Debbie L. Hay;Debbie L. Hay;Stephen G. Howitt;Alex C. Conner;Marcus Schindler.
British Journal of Pharmacology (2003)
Regulation of signal transduction by calcitonin gene-related peptide receptors
Christopher S Walker;Alex C Conner;David R Poyner;Debbie L Hay.
Trends in Pharmacological Sciences (2010)
A second trigeminal CGRP receptor: function and expression of the AMY1 receptor
Christopher S Walker;Sajedeh Eftekhari;Rebekah L Bower;Andrea Wilderman.
Annals of clinical and translational neurology (2015)
Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles
Debbie L. Hay;Augen A. Pioszak.
Annual Review of Pharmacology and Toxicology (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: